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INTRODUCTION
Dyslipidemia refers to the elevation of plasma
cholesterol and/or triglycerides or a low HDL level that
contributes to the development of atherosclerosis and
they can be primary or secondary.1 Primary disorders
are genetically transmitted and are the common cause
in children.2 Secondary causes contribute to most cases
of dyslipidemia in adults and are due to sedentary life-
style with excessive intake of saturated fats, cholesterol
and trans fatty acids. Dyslipidemia itself causes no
symptoms but can lead to coronary artery disease and
peripheral arterial disease. Familial chylomicronemia is
a rare genetic disorder of lipoprotein metabolism with an
incidence of one per million in the general population.3
Clinically, this condition can be silent and discovered
incidentally owing to the lipemic appearance of the
blood. 
Very scarce literature and data is available on
hypertriglyceridemia in children internationally. We
report a rare case of familial chylomicronemia in a 9-
month-old infant.
CASE REPORT
A 9-month-old male child immunized, weighing 7.5 kg,
came to the Outpatient Department with complaints of
abdominal distention and constipation off and on since
the past 7 months. The boy was the product of a
consanguineous marriage, born to a primigravida
mother. Birth history was unremarkable and he had
been breast fed after birth. At 2 months of age, the baby
developed fever, abdominal pain and constipation. For
these complaints, the baby was shown to a private
hospital and was advised some laboratory tests. When
blood was drawn for laboratory tests, it appeared milky
in color. The 8 hours fasting lipid profile of the baby was
done, which showed a total lipids of 640 mg/dl (normal
range= 500– 1000 mg/dl), triglycerides at 430 mg/dl
(normal range= 46–236 mg/dl), cholesterol level of 43
mg/dl (normal range= 160-200 mg/dl) and HDL level of
7 mg/dl (normal range= 35 mg/dl). The baby was put on
skimmed milk. He remained well except for off and on
complaints of constipation and abdominal distension, for
which he presented to this OPD. 
On examination, he was found to be an active boy and
his general physical and systemic examination
including fundoscopy was unremarkable. The lipid
profile and electrophoresis were repeated, the
triglycerides and VLDL were elevated, cholestrol at 128
mg/dl, triglycerides at 692 mg/dl, HDL of 20 mg/dl, LDL
of 40 mg/dl and VLDL of 138 mg/dl (normal < 30 mg/dl).
The lipoprotein electrophoresis showed elevated
chylomicrons and pre-beta lipoprotein. The serum
chylomicrons level was 9.8 REL % (normal range=
0-2.0), beta lipoprotein of 41.7 REL % (normal range=
39.2-65.2), pre-beta lipoprotein of 36.7 REL % (normal
range= 3-30.2) and alpha lipoprotein level of 11.9 REL
% (normal range = 16.7-45.7). On the basis of those
results, the diagnosis of familial chylomicronemia (Type
1 hyperlipidemia) was made; the infant was started on a
low fat diet and advised a regular follow-up. The lipid
profile of the father and mother was also done, which
were normal. 
On his last follow-up, he was one and-a-half years old;
complaints of abdominal distention and constipation had
improved and triglycerides were also decreasing.
DISCUSSION
Familial chylomicronemia is an autosomal recessive
disorder. Familial lipoprotein lipase deficiency usually
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manifests by 10 years of age, and in 25% occurs during
infancy. Often, this condition is silent and the initial clue
to the diagnosis is the presence of lipemic plasma. It
manifests during childhood with lipemia retinalis,
hepatosplenomegaly, irritability and recurrent epigastric
pain with increased risk of pancreatitis. It is
characterized by the pathologic presence of
chylomicrons after a 12-14 hours period of fasting.4
Acute relapsing pancreatitis is the most significant and
often life-threatening complication. 
Eruptive xanthomas present as asymptomatic,
evanescent, yellowish papules over buttocks, shoulders
and extensors of limbs when the serum triglycerides
exceed 2000 mg/dl.5 In the present case, the triglyceride
level was initially 432 mg/dL but had risen to 692 mg/dL.
There was no family history of hypertriglyceridemia and
the lipid profile of parents were normal. Lipoprotein
lipase or Apo C-II deficiency could not be performed as
these tests are done at specialized lipid centers, not
available in Pakistan.
Dietary modification plays a key role in the management
of this disease. Lowering elevated triglyceride level is
beneficial and levels less than 150 mg/dl are desirable.
Dietary fat restriction supplemented by fat soluble
vitamins and including fish oils may also be beneficial.
The intake of saturated fats and trans fatty acids should
be reduced and replaced by polyunsaturated and mono-
unsaturated fats.6 Dietary fat should be restricted to less
than 20 g/day and 15% of the total caloric intake so that
triglyceride levels are maintained below 1500 mg/dL.
Medium-chain triglycerides are the preferred source of
dietary fat.
Intake of fish high in omega-3 fatty acids may be
effective and vegetables can replace animal proteins.7
The complications in these are due to an increase intake
in the amount of fat, which causes recurrent bouts of
illness leading to formation of cysts, hemorrhage and
death. In follow-up of these children, lipid levels should
be monitored periodically after starting treatment.
Dietary counselling and genetic counselling of the family
was advised.8,9
Literature and case reports on hypertriglyceridemia in
pediatric age group is very scarce and there are no
specific treatment guidelines in children. Therefore,
there is a need for consensus suggestions on the
management of these children.
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